AE-19-ZK31_1uM Gene Set
| Dataset |
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
|
| Category |
transcriptomics
|
| Type |
drug perturbation |
| Description |
Dose=1uM, Prinomastat, Angiogenesis Inhibitors;MMP-9 (Gelatinase B) Inhibitors;MMP-2 (Gelatinase A) Inhibitors targeting MMP2, MMP9, MMP14, MMP11, MMP15, MMP16, MMP17, MMP19, MMP23A, MMP20, MMP27, MMP28, MMP21 (Novartis, 466151)
|
| External Link |
https://pubchem.ncbi.nlm.nih.gov/compound/466151
|
| Similar Terms |
|
| Downloads & Tools |
|
Genes
15 genes differentially expressed following the AE-19-ZK31_1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
increased expression
| Symbol |
Name |
Standardized Value |
|
TMEM258
|
transmembrane protein 258
|
0.616298
|
|
RPS13
|
ribosomal protein S13
|
0.488256
|
|
RPL37
|
ribosomal protein L37
|
0.358123
|
|
RHOG
|
ras homolog family member G
|
0.283666
|
|
RNASEH2C
|
ribonuclease H2, subunit C
|
0.272619
|
|
ATP5PO
|
ATP synthase peripheral stalk subunit OSCP
|
0.262609
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
0.262609
|
|
NDUFA11
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa
|
0.262609
|
|
ELOB
|
elongin B
|
0.262609
|
|
FAU
|
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed
|
0.245727
|
|
UBA52
|
ubiquitin A-52 residue ribosomal protein fusion product 1
|
0.208452
|
|
RPL19
|
ribosomal protein L19
|
0.201493
|
decreased expression
| Symbol |
Name |
Standardized Value |
|
CLSTN3
|
calsyntenin 3
|
-0.209708
|
|
CKAP5
|
cytoskeleton associated protein 5
|
-0.206627
|
|
PKM
|
pyruvate kinase, muscle
|
-0.205046
|